Saquinavir Patent Expiration
Saquinavir was first introduced by Hoffmann La Roche Inc
Saquinavir Patents
Given below is the list of patents protecting Saquinavir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fortovase |
US6352717 (Pediatric) | Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses |
May 16, 2020
(Expired) | Hoffmann La Roche |
| Fortovase | US6352717 | Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses |
Nov 16, 2019
(Expired) | Hoffmann La Roche |
| Fortovase |
US6008228 (Pediatric) | Pharmaceutical compositions containing proteinase inhibitors |
Dec 06, 2015
(Expired) | Hoffmann La Roche |
| Fortovase | US6008228 | Pharmaceutical compositions containing proteinase inhibitors |
Jun 06, 2015
(Expired) | Hoffmann La Roche |
Saquinavir's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List